CEA

CEA

CEA is the first of the so-called carcinoembryonic proteins that was discovered in 1965 by Gold and Freeman and is the most widely used marker for gastrointestinal cancer. Although CEA is primarily associated with colorectal cancers, other malignancies that can cause elevated levels of CEA include breast, lung, stomach, pancreas, ovary and other organs

The Fortress Diagnostics CEA can be used for quantitative determination of carcinoembryonic antigen (CEA) concentration in human serum by a microplate immunoenzymometric assay.